7th Annual Hans E. Einstein, M.D. Lecture at Barlow Respiratory Hospital

Join your colleagues and the pulmonary/critical care community for

IMPLICATIONS OF STAPHYLOCOCCAL RESISTANCE IN THE CRITICALLY ILL PATIENT

Stanley C. Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford University School of Medicine, Stanford, California

Sponsored by Barlow Respiratory Hospital and Research Center and Office of Continuing Medical Education, Keck School of Medicine of the University of Southern California. Supported by an educational grant from Pfizer, Inc.

DATE

Tuesday, November 13, 2007 at the Annual Meeting of the Medical Staff of Barlow Respiratory Hospital

PLACE

Barlow Respiratory Hospital
2000 Stadium Way
Los Angeles, CA 90026

TIME

6:00 p.m. - Social Hour, Library
7:00 p.m. - Dinner, Dining Room
8:00 p.m. - Scientific Session, Williams Hall

Description:

Staphylococcus aureus has become resistant to many commonly used antibiotics. The emergence of antimicrobial resistance, including MRSA, makes the choice of antimicrobial therapy in critically ill patients a rapidly changing area of infectious disease medicine, and one in which physicians need to remain current, as MRSA can lead to life-threatening diseases, such as pneumonia, meningitis, endocarditis, toxic shock syndrome (TSS), and septicemia. This is of particular importance to pulmonologists and critical care physicians/intensivists responsible for the care of patients in intensive care units (ICU). This lecture will provide an update on recognition, current management, and antimicrobial therapy in staphylococcal resistance in the critically ill patient. This program is designed for physicians specializing in Pulmonary and Critical Care Medicine, Internal Medicine, Respiratory Therapists, and ICU Nurses; however, everyone is welcome.

Objectives:

At the end of the presentation the participant should be able to:
Recognize the importance of staphylococcal resistance in the critically ill patient
Discuss the limitations of vancomycin as an anti-staphylococcal agent
Determine the appropriate selection of antimicrobial therapy in the critically ill patient in light of the emergence of MRSA ACCREDITATION: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Keck School of Medicine of the University of Southern California and Barlow Respiratory Hospital. The Keck School of Medicine of the University of Southern California is accredited by the ACCME to provide continuing medical education for physicians.

The Keck School of Medicine of the University of Southern California designates this educational activity for a maximum of 1 AMA PRA Category 1 creditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal.